By Eric Langer
Hiring of bioprocessing professionals has remained a stubborn problem over the past 11 years, and will only get worse, according to BioPlan’s 17th Annual Report and Survey of Biopharmaceutical Manufacturing. This is bad news for bioprocessing, but potentially good news for experienced staff seeking career advancement. As demand for expertise grows, the supply of qualified staff will continue to get tighter. This can be particularly challenging for start-up companies who need to attract skilled, experienced staff.
This skills shortage will get worse as competition for expertise grows: New facilities, new technologies, biosimilars, cell and gene therapies, industry expansion to developing markets, notably China and elsewhere are contributing to the ‘pinch’.